PE Tech Report


Like this article?

Sign up to our free newsletter

Hedera Dx raises €14m in seed funding round led by Top Harvest founder Ghobarah

Swiss techbio company Hedera Dx, founded in 2021 by veteran healthcare entrepreneurs and executives, has raised€14 million a seed finding round led by Adam Ghobarah, founder of Top Harvest Capital and former longtime executive at Google and Google Ventures.

Inventure, Air Street Capital, Amino Collective and GRIDS Capital also participated in the round with the funds set to be used to launch a new blood-based testing solution to profile cancer DNA circulating in the blood, helping patients access better treatments. 

In addition to launching commercially, the company will use the funding to implement the first phase of a large oncology Real World Evidence (RWE) clinical testing program.

Hedera Dx’s new solution aims to radically streamlines the process of finding the right regulatory-approved therapy for each cancer patient, enabling hospital labs to run clinically actionable liquid biopsies in-house.

Like this article? Sign up to our free newsletter